Identification of Amino-Terminally Cleaved Tau Fragments That Distinguish Progressive Supranuclear Palsy from Corticobasal Degeneration

Annals of Neurology

Volumn 55, Issue 1, 2004, Pages 72-79

  Arai, Tetsuaki ^a   Ikeda, Kenji ^a   Akiyama, Haruhiko ^a   Nonaka, Takashi ^a   Hasegawa, Masato ^a   Ishiguro, Koichi ^b   Iritani, Shuji ^c   Tsuchiya, Kuniaki ^c   Iseki, Eizo ^d   Yagishita, Saburo ^e   Oda, Tatsuro ^f   Mochizuki, Akihide ^g  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

^c TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e KANAGAWA REHABILITATION CENTER   (Japan)

^f National Hospital Organization Shimofusa Psychiatric Medical Center   (Japan)

^g UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; TAU PROTEIN;

ADULT; AGED; AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BASAL GANGLION; BRAIN; BRAIN CORTEX; BRAIN LEVEL; BRAIN TISSUE; CARBOXY TERMINAL SEQUENCE; CELL INCLUSION; CHEMISTRY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MICROTUBULE; MOLECULAR GENETICS; NEUROPATHOLOGY; PATHOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PROCESSING; TAUOPATHY;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BASAL GANGLIA; BRAIN; BRAIN CHEMISTRY; CEREBRAL CORTEX; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS; TAUOPATHIES;

EID: 9144224301     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10793     Document Type: Article

References (38)

1. Buée L, Bussiére T, Buée-Scherrer V, et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 2000;33:95-130.
2. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964;10:333-359.
3. Hauw J-J, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-2019.
4. Hauw J-J, Verny M, Delaére P, et al. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging. Neurosci Lett 1990;119:182-186.
5. Hof PR, Delacourte A, Bouras C. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (Berl) 1992;84:45-51.
6. Uchihara T, Mitani K, Mori H, et al. Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer's disease or progressive supranuclear palsy. Acta Neuropathol (Berl) 1994;88:379-383.
7. Dickson DW, Bergeron C, Chin SS, et al. Office of rare disease neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935-946.
8. Yamada T, McGeer PL, McGeer EG. Appearance of paired nucleated, tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett 1992;135:99-102.
9. Ikeda K, Akiyama H, Arai T, Nishimura T. Glial tau pathology in neurodegenerative disease: their nature and comparison with neuronal tangles. Neurobiol Aging 1998;19:S85-S91.
10. Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995;146:1388-1396.
11. Komori T, Arai N, Oda M, et al. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 1998;96:401-408.
12. Ikeda K, Akiyama H, Haga C, et al. Argyrophilic thread-like structure in corticobasal degeneration and progressive supranuclear palsy. Neurosci Lett 1994;174:157-159.
13. Goedert M, Spillantini MG, Jakes R, et al. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989;3:519-526.
14. Goedert M, Spillantini MG, Potier MC, et al. Cloning and sequencing of the cDNA encoding an isoforms of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 1989;8:393-399.
15. Goedert M, Spillantini MG, Cairns NJ, Crowther RA. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 1992;8:159-168.
16. Delacourte A, Sergeant N, Wattez A, et al. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation. Ann Neurol 1998;43:193-204.
17. Arai T, Ikeda K, Akiyama H, et al. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 2001;101:167-173.
18. Sergeant N, Wattez A, Delacourte A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. J Neurochem 1999;72:1243-1249.
19. Arai T, Ikeda K, Akiyama H, et al. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol (Berl) 2003;105:489-498.
20. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999;8:711-715.
21. Di Maria E, Tabaton M, Vigo T, et al. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 2000;47:374-377.
22. Arai T, Ikeda K, Akiyama H, et al. Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy. Neuroreport 2001;12:935-938.
23. Katsuse O, Iseki E, Arai T, et al. 4-Repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) (in press).
24. Ikeda K. Basic pathology of corticobasal degeneration. Neuropathology 1997;17:127-133.
25. Matsusaka H, Ikeda K, Akiyama H, et al. Astrocytic pathology in progressive supranuclear palsy: significance for neuropathological diagnosis. Acta Neuropathol (Berl) 1998;96:248-252.
26. Endoh R, Ogawara M, Iwatsubo T, et al. Lack of the carboxyl terminal sequence of tau in ghost tangle of Alzheimer's disease. Brain Res 1993;601:164-172.
27. Greenberg SG, Davies P. A preparation of Alzheimer paired helical filaments that displays distinct τ proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 1990;87:5827-5831.
28. Matsudaira P. Sequence from picomole quantities of protein electroblotted onto polyvinyldene difluoride membranes. J Biol Chem 1987;262:10035-10038.
29. Liu W-K, Le TV, Adamson J, et al. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann Neurol 2001;50:494-502.
30. Forman MS, Zhukareva V, Bergeron C, et al. Signature tau neuropathology in gray and white matter of corticobasal degeneration. Am J Pathol 2002;160:2045-2053.
31. Kondo J, Honda T, Mori H, et al. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1988;1:827-834.
32. Novak M, Kabat J, Wischik W. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's paired helical filament. EMBO J 1993;12:365-370.
33. Johson GVW, Seubert P, Cox TM, et al. The τ protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J Neurochem 1997;68:430-433.
34. Ishiguro K, Ohno H, Arai H, et al. Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease. Neurosci Lett 1999;270:91-94.
35. Wolozin GL, Pruchnicki A, Dickson DW, Davies P. A neuronal antigen in the brain of Alzheimer's patients. Science 1986;232:648-650.
36. Ishiguro K, Sato K, Takamatsu M, et al. Analysis of phosphorylation of tau with antibodies specific for phosphorylation site. Neurosci Lett 1995;202:81-84.
37. Greenberg SG, Davies P, Schein JD, Binder LI. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 1992;267:564-569.
38. Morishima-Kawashima M, Hasegawa M, Takio K, et al. Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem 1995;270:823-829.